The risk of chemical interaction, precipitation, or degradation is just too high
Zhao Z, Nelson AR, Betsholtz C, Zlokovic BV
Yes, peptide therapy can be highly effective when combined with GLP-1 therapies
200 Bellevue, WA 98006, USA * Correspondence: Loren Pickart Academic Editors: Luis Martinez and Michael Fossel Received: June 8, 2018 | Accepted: August 2, 2018 | Published: August 16, 2018 OBM Geriatrics 2018 , Volume 2, Issue 3 doi:10.21926/obm.geriatr.1803009 Recommended citation: Pickart L, Margolina A
However, in old people, the ability to produce nitric oxide in the artery linings decreases
There's also a peptide called GIP (glucose-dependent insulinotropic polypeptide), a 42-amino-acid hormone secreted by the small intestine that makes insulin more efficient and works as an appetite suppression booster alongside GLP-1